SK Biopharmaceuticals (326030:KS) PT Lowered to KRW100,000 at Citi

November 29, 2022 10:16 AM EST
Get Alerts 326030:KS Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 8
Join SI Premium – FREE
Citi lowered its price target on SK Biopharmaceuticals (326030:KS) to KRW100,000.00 (from KRW122,000.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings